Due to restrictions following results are derived from synthetic data to demonstrate capability of Computational Healthcare. Please do no derive any inferences from results below.

Rehospitalizations

Numerator 200

Discharged

Denominator 860

Rehospitalization Rate

200 / 860 = 23.3 %

Index = Discharged + Died + Transferred

930 (100%) = 860 (92.5%) + 0 (0.0%) + 0 (0.0%)

Aggregation Policy
Minimum count20
Multiple10
Min hospitals2
Min subset200

Rehospitalization during 50 days since discharge:

Mean ΔT: 21.29 days FQ: 8 days Median: 18 days TQ: 34 days

Rehospitalization during 50 weeks since discharge:

Mean ΔT: 2.6 weeks FQ: 1 weeks Median: 2 weeks TQ: 4 weeks
Sex Distribution
Sex Initial Sub Discharged
Male 55.0 % 55.0 % 44.19 %
Female 40.0 % 40.0 % 53.49 %
Race Distribution
Race Initial Sub Discharged
White 15.0 % 15.0 % 13.95 %
Black 15.0 % 10.0 % 15.12 %
Hispanic 15.0 % 10.0 % 12.79 %
Asian or Pacific Islander 0.0 % 15.0 % 11.63 %
Native American 15.0 % 15.0 % 15.12 %
Other 15.0 % 15.0 % 13.95 %
Race missing, unknown 10.0 % 10.0 % 13.95 %
Payer Distribution
Payer Initial Sub Discharged
Medicare 15.0 % 10.0 % 15.12 %
Medicaid 10.0 % 10.0 % 12.79 %
Private insurance 10.0 % 10.0 % 13.95 %
Self-pay 15.0 % 15.0 % 13.95 %
Other payer 10.0 % 15.0 % 13.95 %
Unknown payer 15.0 % 10.0 % 11.63 %
No charge 15.0 % 10.0 % 15.12 %
Source Distribution
Source Initial Sub Discharged
Another health facility including LTC 20.0 % 15.0 % 18.6 %
Emergency department 15.0 % 15.0 % 18.6 %
Unknown 15.0 % 15.0 % 13.95 %
Court/Law enforcement 20.0 % 10.0 % 16.28 %
Routine, birth, etc 10.0 % 15.0 % 15.12 %
Another hospital 15.0 % 15.0 % 13.95 %
Disposition Distribution
Disposition Initial Sub Discharged
Home Health Care 25.0 % 15.0 % 18.6 %
Died in hospital 0.0 % 15.0 % 0.0 %
Transfer other SNF, ICF, etc. 20.0 % 15.0 % 18.6 %
Routine 50.0 % 40.0 % 60.47 %
Length of Stay Distribution
Discharged
Initial
Subsequent
Visits Mean LOS First quartile Median Third quartile
Discharged 8.43 days 2 days 5 days 11 days
Initial 10.21 days 5 days 7 days 13 days
Sub 7.01 days 3 days 5 days 9 days
Age Distribution
Discharged
Initial
Subsequent
Visits Mean Age First quartile Median Third quartile
Discharged 65.56 year 55 year 67 year 77 year
Initial 68.21 year 59 year 70 year 78 year
Sub 68.36 year 59 year 69 year 80 year
Procedure Distribution
Procedure Code Description Initial Sub Discharged
P3491 Thoracentesis 0.0 % 0.0 % 2.33 %
P3893 Venous catheterization, not elsewhere classified 10.0 % 10.0 % 5.81 %
P3324 Closed [endoscopic] biopsy of bronchus 0.0 % 0.0 % 2.33 %
P3326 Closed [percutaneous] [needle] biopsy of lung 0.0 % 0.0 % 2.33 %
P9925 Injection or infusion of cancer chemotherapeutic substance 25.0 % 10.0 % 12.79 %
P9904 Transfusion of packed cells 15.0 % 20.0 % 12.79 %
P9229 Other radiotherapeutic procedure 100.0 % 20.0 % 100.0 %
DRG Distribution
DRG Code Description Initial Sub Discharged
DG409 DRG V24 : RADIOTHERAPY 0.0 % 0.0 % 5.81 %
DG410 DRG V24 : CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS 0.0 % 0.0 % 2.33 %
DG301 DRG V24 : ENDOCRINE DISORDERS W/O CC 0.0 % 0.0 % 16.28 %
DG300 DRG V24 : ENDOCRINE DISORDERS W CC 0.0 % 0.0 % 4.65 %
DG403 DRG V24 : LYMPHOMA & NON-ACUTE LEUKEMIA W CC 0.0 % 0.0 % 2.33 %
DG82 DRG V24 : RESPIRATORY NEOPLASMS 10.0 % 10.0 % 6.98 %
DG239 DRG V24 : PATHOLOGICAL FRACTURES & MUSCULOSKELETAL & CONN TISS MALIGNANCY 10.0 % 0.0 % 9.3 %
DG10 DRG V24 : NERVOUS SYSTEM NEOPLASMS W CC 10.0 % 0.0 % 9.3 %
Diagnosis Distribution
Diagnosis Code Description Initial Primary Sub Primary Discharged Primary Initial All Sub All Discharged All
DV580 Encounter for radiotherapy 0.0% 0.0% 5.81% 0.0% 0.0% 5.81%
D2859 Anemia, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 5.81%
D78701 Nausea with vomiting 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
DV103 Personal history of malignant neoplasm of breast 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D19889 Secondary malignant neoplasm of other specified sites 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D3051 Tobacco use disorder 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
DV5811 Encounter for antineoplastic chemotherapy 0.0% 0.0% 2.33% 0.0% 0.0% 3.49%
D1977 Malignant neoplasm of liver, secondary 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
D2449 Unspecified acquired hypothyroidism 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D56400 Constipation, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
D1970 Secondary malignant neoplasm of lung 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
D25000 Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled 0.0% 0.0% 0.0% 0.0% 0.0% 5.81%
D30000 Anxiety state, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D1629 Malignant neoplasm of bronchus and lung, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
DV1582 Personal history of tobacco use 0.0% 0.0% 0.0% 10.0% 10.0% 8.14%
D3383 Neoplasm related pain (acute) (chronic) 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D193 Malignant neoplasm of thyroid gland 0.0% 0.0% 20.93% 0.0% 0.0% 23.26%
D311 Depressive disorder, not elsewhere classified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D2761 Hyposmolality and/or hyponatremia 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D4019 Unspecified essential hypertension 0.0% 0.0% 0.0% 15.0% 10.0% 18.6%
D2724 Other and unspecified hyperlipidemia 0.0% 0.0% 0.0% 0.0% 0.0% 5.81%
D496 Chronic airway obstruction, not elsewhere classified 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D2720 Pure hypercholesterolemia 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D1983 Secondary malignant neoplasm of brain and spinal cord 0.0% 0.0% 9.3% 10.0% 10.0% 8.14%
D53081 Esophageal reflux 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D1985 Secondary malignant neoplasm of bone and bone marrow 10.0% 0.0% 9.3% 20.0% 15.0% 12.79%
D1960 Secondary and unspecified malignant neoplasm of lymph nodes of head, face, and neck 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D2768 Hypopotassemia 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D5990 Urinary tract infection, site not specified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D28522 Anemia in neoplastic disease 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D73300 Osteoporosis, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D27651 Dehydration 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
External Causes Distribution
External Cause Code Description Initial Sub Discharged
EE8497 Accidents occurring in residential institution 10.0 % 0.0 % 10.47 %
EE9331 Antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use 0.0 % 0.0 % 6.98 %
EE9320 Adrenal cortical steroids causing adverse effects in therapeutic use 0.0 % 0.0 % 3.49 %
EE8490 Accident in home 0.0 % 10.0 % 4.65 %